Elizabeth A King (Elizabeth King)

Years Active: 2022-2023
Publications (10 Years): 2

This page only lists publications with an associated author ORCID identifier.

Publications

Teena Bajaj, Eddie Wehri, Rahul K Suryawanshi, Elizabeth A King, Kundan Singh Pardeshi, Kamyar Behrouzi, Zahra Khodabakhshi, Ursula Schulze-Gahmen, G Renuka Kumar, Mohammad R K Mofrad, Daniel K Nomura, Melanie Ott, Julia Schaletzky, Niren Murthy
Mercapto-pyrimidines are reversible covalent inhibitors of the papain-like protease (PLpro) and inhibit SARS-CoV-2 (SCoV-2) replication. RSC advances 13 (26) (2023)
Xinrong Tian, Dominic Suarez, Douglas Thomson, William Li, Elizabeth A King, Louis LaFrance, Jeffrey Boehm, Linda Barton, Christina Di Marco, Cuthbert Martyr, Reema Thalji, Jesus Medina, Steven Knight, Dirk Heerding, Enoch Gao, Eldridge Nartey, Ted Cecconie, Christopher Nixon, Guofeng Zhang, Thomas J Berrodin, Christopher Phelps, Amish Patel, Xiaopeng Bai, Ken Lind, Ninad Prabhu, Jeffrey A Messer, Zhengrong Zhu, Lisa Shewchuk, Rob Reid, Alan P Graves, Charles McHugh, Biju Mangatt
Discovery of Proline-Based p300/CBP Inhibitors Using DNA-Encoded Library Technology in Combination with High-Throughput Screening. Journal of medicinal chemistry 65 (21) (2022)

Elizabeth A King.css-eqlu8i{font-size:small;padding-left:4px;} (Elizabeth King)